Carafate
NDC 58914-170, Sucralfate, suspension, from Allergan, Inc..
- Product NDC
- 58914-170
- Status
- Listed
- Labeler
- Allergan, Inc.
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA019183
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/58914-170 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SUCRALFATE1 g/10mL
Pharmacologic classes
Aluminum Complex [EPC]; Organometallic Compounds [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 58914-170-14 | 58914017014 | 420 mL in 1 BOTTLE (58914-170-14) |
| 58914-170-60 | 58914017060 | 6 CUP, UNIT-DOSE in 1 BOX (58914-170-60) / 10 mL in 1 CUP, UNIT-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/0fb67b1c-b4c0-46f2-8a81-df1510e006aa
Use it
Look up 58914-170 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/58914-170 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 58914-170. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.